On 22 October 2025, Alligator Bioscience announced the board of directors’ decision to carry out a rights issue with preferential rights, subject to subsequent approval by the Extraordinary General Meeting.
Preliminary timeline
| 24 November 2025 | Publication of final terms of the Rights Issue, including Subscription Price |
| 25 November 2025 | Extraordinary general meeting |
| 28 November 2025 | Estimated publication of the Prospectus |
| 28 November 2025 | Last day of trading incl. preferential rights |
| 1 December 2025 | First day of trading excl. preferential rights |
| 2 December 2025 | Record date in the Rights Issue |
| 4 – 15 December 2025 | Trading in unit rights |
| 4 – 18 December 2025 | Subscription period |
| 22 December 2025 | Estimated publication of the outcome of the Rights Issue |
| 4 December 2025 – 13 January 2026 | Trading in paid subscribed units (BTU) |
The application form is available under the tab “Financial reports and other documentation” below. For digital signing with Swedish BankID, please visit Vator Securities’ transaction page.
The application forms are primarily intended for shareholders with directly registered holdings (VP accounts). Shareholders holding shares through a nominee/custodian should subscribe through their nominee.
Video interviews – the Rights Issue
- English video (BioStock): CEO Søren Bregenholt (opens on BioStock)
- Swedish video (Redeye): CFO Johan Giléus (opens on Redeye)